Caterina Vivaldi

机构：University of Pisa, Azienda Ospedaliera Universitaria Pisana · ORCID：0000-0001-9307-2326

发表论文 343 篇 · 总被引 3950 次 · h-index 34

代表论文

• The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer (2026 · The Lancet Oncology · 被引 7)
• Molecular profiling and matched targeted treatment in cholangiocarcinoma: Results from the Italian dataset (ANITA) (2025 · Journal of Hepatology · 被引 6)
• Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab (2025 · Scientific Reports · 被引 4)
• Long-term outcomes of atezolizumab–bevacizumab in unresectable hepatocellular carcinoma: A real-world study (2026 · Hepatology · 被引 3)
• A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma (2026 · Journal of Hepatology · 被引 2)
• The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study (2026 · The Lancet Digital Health · 被引 2)